Reduced cholecystokinin levels in cerebrospinal fluid of parkinsonian and schizophrenic patients. Effect of ceruletide in schizophrenia.
D000328:Adult; D000368:Aged; D002108:Ceruletide / Q000627:therapeutic use*; D002766:Cholecystokinin / Q000134:cerebrospinal fluid*; D002986:Clinical Trials as Topic; D004298:Dopamine / Q000378:metabolism; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000134:cerebrospinal fluid*; D012559:Schizophrenia / Q000134:cerebrospinal fluid / Q000188:drug therapy*
D002108:Ceruletide; D002766:Cholecystokinin; D004298:Dopamine